Polyvalent pneumococcal polysaccharide-protein conjugate composition
US10058607B2 · kind B2 · utility
12Cited by
13References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2017 |
| Grant date | Aug 28, 2018 |
| Priority date | — |
| Expiry date | May 2, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is an immunogenic composition comprising 15 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 9N, 9V, 14, 18C, 19A, 19F and 23F. An immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases application range with respect to pneumococcal diseases in infants and children.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.